[DOI] [Google Scholar] 25.Gao S, et al
Program retention is one of the biggest challenges GLP-1 users face today between side effects, cost, duration, and the mental health aspects of treatment, many patients stop taking the medication within just months
In contrast, weekly injectable pens reduce daily pill burden and may simplify adherence for some individuals
Methods We searched PubMed, Scopus, Embase, Web of Science and Google Scholar from inception to September 2025 for studies reporting the prevalence of migraine in rhinitis patients
Diab Obes Metab
Tirzepatide may be appropriate for individuals who: Have a BMI of 30 or higher (obesity), or 27 or higher with a weight-related health condition such as hypertension, type 2 diabetes, or dyslipidemia Have not achieved adequate results through diet and exercise alone Have pre-diabetes and need improved blood sugar control and weight management Are committed to ongoing medical supervision and lifestyle support throughout treatment Tirzepatide is not appropriate for individuals who: Have a personal or family history of medullary thyroid carcinoma Are pregnant or planning to become pregnant Have a known hypersensitivity reaction to tirzepatide or its ingredients Have a history of confirmed pancreatitis (discuss with provider) If you are considering tirzepatide and want a comprehensive assessment of whether it is appropriate for your specific health profile, TRT Nations Medical Weight Loss Assessment is a clinically guided starting point designed to help patients and providers align on the right treatment approach
